Principal Financial Group Inc. Sells 60,807 Shares of Sotera Health (NASDAQ:SHC)

Principal Financial Group Inc. reduced its stake in shares of Sotera Health (NASDAQ:SHC - Free Report) by 14.7% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 354,025 shares of the company's stock after selling 60,807 shares during the quarter. Principal Financial Group Inc. owned 0.12% of Sotera Health worth $5,912,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Retirement Systems of Alabama raised its holdings in shares of Sotera Health by 20.8% during the 3rd quarter. Retirement Systems of Alabama now owns 185,779 shares of the company's stock worth $3,103,000 after buying an additional 32,051 shares in the last quarter. Sanctuary Advisors LLC raised its stake in Sotera Health by 154.4% during the third quarter. Sanctuary Advisors LLC now owns 29,088 shares of the company's stock worth $486,000 after acquiring an additional 17,652 shares in the last quarter. Neo Ivy Capital Management bought a new position in shares of Sotera Health in the third quarter worth about $720,000. Geode Capital Management LLC boosted its stake in shares of Sotera Health by 19.4% in the 3rd quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company's stock valued at $46,026,000 after purchasing an additional 447,186 shares in the last quarter. Finally, Barclays PLC grew its holdings in shares of Sotera Health by 169.8% during the 3rd quarter. Barclays PLC now owns 473,597 shares of the company's stock valued at $7,909,000 after purchasing an additional 298,085 shares during the last quarter. Institutional investors own 91.03% of the company's stock.

Sotera Health Stock Down 0.4 %

Sotera Health stock traded down $0.06 during midday trading on Thursday, reaching $13.62. The stock had a trading volume of 648,956 shares, compared to its average volume of 1,328,794. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. Sotera Health has a 12 month low of $10.71 and a 12 month high of $17.44. The company has a fifty day moving average price of $14.05 and a two-hundred day moving average price of $14.32. The company has a market capitalization of $3.86 billion, a P/E ratio of 54.48 and a beta of 1.96.

Sotera Health (NASDAQ:SHC - Get Free Report) last announced its earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). The company had revenue of $285.47 million for the quarter, compared to analysts' expectations of $278.64 million. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The firm's quarterly revenue was up 8.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.18 EPS. As a group, equities analysts expect that Sotera Health will post 0.61 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on SHC shares. Citigroup upped their price target on shares of Sotera Health from $18.00 to $20.00 and gave the stock a "buy" rating in a report on Wednesday, November 6th. Royal Bank of Canada reiterated an "outperform" rating and set a $17.00 target price on shares of Sotera Health in a research report on Thursday, November 21st. Finally, The Goldman Sachs Group started coverage on shares of Sotera Health in a research report on Friday, December 6th. They issued a "neutral" rating and a $14.00 price target for the company. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $16.08.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.